<?xml version="1.0" ?>
<document id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83">
  <chunk id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c0" text="Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome">
    <entity charOffset="39-47" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c0.e0" ontology_id="HP_0012824" text="severity" type="phenotype"/>
    <entity charOffset="51-57" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c0.e1" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="58-63" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c0.e2" ontology_id="HP_0001945" text="fever" type="phenotype"/>
    <entity charOffset="69-85" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c0.e3" ontology_id="HP_0001873" text="thrombocytopenia" type="phenotype"/>
  </chunk>
  <chunk id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1" text="Background: Severe fever with thrombocytopenia syndrome (SFTS) was an emerging hemorrhagic fever that was caused by a tick-borne bunyavirus, SFTSV. Although SFTSV nonstructural protein can inhibit type I interferon (IFN-I) production Ex Vivo and IFN-I played key role in resistance SFTSV infection in animal model, the role of IFN-I in patients is not investigated. Methods: We have assayed the concentration of IFN-α, a subtype of IFN-I as well as other cytokines in the sera of SFTS patients and the healthy population with CBA (Cytometric bead array) assay.">
    <entity charOffset="12-18" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e0" ontology_id="HP_0012828" text="Severe" type="phenotype"/>
    <entity charOffset="19-24" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e1" ontology_id="HP_0001945" text="fever" type="phenotype"/>
    <entity charOffset="30-46" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e2" ontology_id="HP_0001873" text="thrombocytopenia" type="phenotype"/>
    <entity charOffset="91-96" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e3" ontology_id="HP_0001945" text="fever" type="phenotype"/>
    <entity charOffset="472-476" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e4" ontology_id="GO_0004617" text="sera" type="gene_function"/>
    <entity charOffset="502-509" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e5" ontology_id="HP_0032322" text="healthy" type="phenotype"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e0" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e4" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.p0" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e1" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e4" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.p1" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e2" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e4" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.p2" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e3" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e4" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.p3" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e4" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.e5" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c1.p4" relation="true"/>
  </chunk>
  <chunk id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2" text="The results showed that IFN-α, tumor necrosis factor (TNF-α), granulocyte colony-stimulating factor (G-CSF), interferon-γ (IFN-γ), macrophage inflammatory protein (MIP-1α), interleukin-6 (IL-6), IL-10, interferon-inducible protein (IP-10), monocyte chemoattractant protein (MCP-1) were significantly higher in SFTS patients than in healthy persons (p &lt; 0.05); the concentrations of IFN-α, IFN-γ, G-CSF, MIP-1α, IL-6, and IP-10 were significant higher in severe SFTS patients than in mild SFTS patients (p &lt; 0.05). Conclusion: The concentration of IFN-α as well as other cytokines (IFN-γ, G-CSF, MIP-1α, IL-6, and IP-10) is correlated with the severity of SFTS, suggesting that type I interferon may not be significant in resistance SFTSV infection in humans and it may play an import role in cytokine storm.">
    <entity charOffset="31-36" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e0" ontology_id="HP_0002664" text="tumor" type="phenotype"/>
    <entity charOffset="37-45" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e1" ontology_id="GO_0001906" text="necrosis" type="gene_function"/>
    <entity charOffset="332-339" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e2" ontology_id="HP_0032322" text="healthy" type="phenotype"/>
    <entity charOffset="454-460" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e3" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="483-487" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e4" ontology_id="HP_0012825" text="mild" type="phenotype"/>
    <entity charOffset="643-651" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e5" ontology_id="HP_0012824" text="severity" type="phenotype"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e0" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e1" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.p0" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e1" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e2" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.p1" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e1" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e3" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.p2" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e1" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e4" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.p3" relation="true"/>
    <pair e1="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e1" e2="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.e5" id="ce90f3248a2ef874c0d7cfe5926a3ca6e56a7f83.c2.p4" relation="true"/>
  </chunk>
</document>
